This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Cinakate Pharm Tech (Shanghai) Co., Ltd., Cinkate Pharmaceutical Intermediates Co., Ltd.. Active years: 2023.
Company Filing History:
1 out of 1 
1 out of 2 Years Active: 2023
Title: Lixia Bao: Innovator in Pharmaceutical Chemistry
Introduction
Lixia Bao is a notable inventor based in Shanghai, China. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications. Her work focuses on creating effective immunosuppressive drugs, which are crucial for various therapeutic interventions.
Latest Patents
Lixia Bao holds a patent for "Substituted pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors." This invention provides a method for preparing a pyrrolopyrimidine compound and its applications. Specifically, it includes a compound represented by a specific formula or its pharmaceutically acceptable salts, along with a pharmaceutical composition containing the compound. The patent also outlines a method for preparing the pharmaceutical composition and its application as an immunosuppressive drug.
Career Highlights
Throughout her career, Lixia Bao has worked with several companies, including Cinakate Pharm Tech (Shanghai) Co., Ltd. and Cinkate Pharmaceutical Intermediates Co., Ltd. Her experience in these organizations has allowed her to develop her expertise in pharmaceutical research and innovation.
Collaborations
Lixia Bao has collaborated with notable colleagues, including Na Liu and Zhepeng Wei. These partnerships have contributed to her success in the field and have facilitated the advancement of her research projects.
Conclusion
Lixia Bao is a prominent inventor whose work in pharmaceutical chemistry has led to significant advancements in immunosuppressive drug development. Her innovative approach and dedication to research continue to impact the medical field positively.